Posted by Michael Wonder on 18 Dec 2018
Our door is open: FDA puts patients first
18 December 2018 - We believe patients are experts when it comes to their health conditions.
Ultimately, they’re the ones who can share aspects of their diseases that even our most qualified doctors and scientists couldn’t possibly know. This valuable patient input is a critical part of our understanding of diseases and conditions that may help us to advance medical product development.
For this reason, patients are at the forefront of everything we do. Supporting and understanding the patient experience and incorporating patient feedback into our work is an agency-wide priority. More and more, we are integrating patient perspectives throughout the lifecycle of product development and regulation.
A year ago this month, the FDA established the Patient Affairs Staff in the Office of the Commissioner to build on and further improve our 30+ years of engagement with patient communities.
